Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Europe
Europe
Sarepta Wins Exclusive License, Collaboration Deal for European Rights To Summit's DMD Drug
Yahoo/Benzinga
Tue, 10/4/16 - 03:58 pm
Sarepta Therapeutics
Europe
Duchenne Muscular Dystrophy
Summit Therapeutics
ezutromid
Pfizer gets green light for Ibrance in EU
BioPharma Dive
Mon, 09/19/16 - 06:05 pm
Pfizer
Ibrance
Europe
breast cancer
J&J, GSK advance their PhIII IL-6 rheumatoid arthritis drug down to a busy red zone
Endpoints
Tue, 09/13/16 - 10:06 am
JNJ
GSK
rheumatoid arthritis
sirukumab
FDA
Europe
Drug maker loses appeal of antitrust pay-to-delay case in Europe
Stat/Pharmalot
Fri, 09/9/16 - 10:23 am
pay-for-delay
Lundbeck
Europe
antidepressants
Pfizer Gets European Approval For XALKORI, A Cell Lung Cancer Treatment
Yahoo/Benzinga
Thu, 09/1/16 - 09:23 am
Pfizer
Europe
Xalkori
non-small cell lung cancer
Could Pfizer Face An Apple-Like Tax Surprise in the EU?
Motley Fool
Wed, 08/31/16 - 09:12 am
Pfizer
Europe
taxes
Gilead Sciences, Inc. to Extend Reach in HIV Drugs Market Via Truvada’s Approval
Bidness, ETC
Wed, 08/24/16 - 10:41 am
Gilead Sciences
Truvada
HIV
Europe
Merck’s KEYTRUDA® (pembrolizumab) Approved by the European Commission for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1
Yahoo
Wed, 08/3/16 - 09:02 am
Merck
Keytruda
Europe
non-small cell lung cancer
'Sunshine' hits Europe: Pharma's doc payments now available, but numbers are far from comprehensive
Fierce Pharma
Mon, 07/25/16 - 11:18 am
Europe
physicians
physician payments
Physician Payment Sunshine Act
Gilead Gets European CHMP's Positive Opinion On Its Type II Variation Application For Truvada
Yahoo
Sat, 07/23/16 - 10:43 am
Gilead Sciences
Europe
CHMP
Truvada
HIV
Mylan gets 'all clear' from EU regulators for $7.2 billion Meda deal
BioPharma Dive
Thu, 07/21/16 - 09:20 pm
Mylan Labs
Europe
Meda
M&A
New CEO Szela cuts Aegerion staff again, pulls Juxtapid out of the EU
Endpoints
Thu, 07/21/16 - 09:14 am
Aegerion Pharmaceuticals
layoffs
Juxtapid
Europe
Pharma CEOs
Mary Szela
AZ's FDA-rejected diabetes combo grabs first-to-market status in Europe
Fierce Pharma
Wed, 07/20/16 - 11:02 am
AstraZeneca
diabetes
Europe
FDA
Qtern
Farixga
Onglyza
GlaxoSmithKline and AstraZeneca Form Brexit Task Force
Xtalks
Tue, 07/12/16 - 06:57 pm
GSK
AstraZeneca
UK
Europe
Brexit
Gilead secures European approval for new hepatitis C drug
BioPharma Dive
Mon, 07/11/16 - 11:23 am
Gilead Sciences
Europe
hepatitis C
Epclusa
Seattle Genetics drug gets OK for additional cancer therapies in Europe
Bizjournals.com
Wed, 07/6/16 - 11:08 am
Seattle Genetics
Europe
Adcetris
Hodgkin's lymphoma
Brexit’s Impact on Pharmaceutical Research and Development
Market Realist
Wed, 06/29/16 - 10:48 am
Brexit
Europe
UK
R&D
Shire and Glaxo Offer Prescription to London's Woes
TheStreet.com
Tue, 06/28/16 - 11:16 am
Shire
GSK
Brexit
UK
EU
Europe
UK pharma trade group on Brexit: ‘There’s a potentially negative story here’
Stat
Mon, 06/27/16 - 11:09 pm
UK
Brexit
Europe
Association of the British Pharmaceutical Industry
GSK, GILD, AZN: How Brexit Affects Drug Stocks
Bidness, ETC
Mon, 06/27/16 - 11:08 pm
GSK
Gilead Sciences
AstraZeneca
Brexit
UK
Europe
Pages
« first
‹ previous
…
26
27
28
29
30
31
32
33
34
…
next ›
last »